Endoscopy

United Digestive Recognized Among Top 6 Gastroenterology Companies to Watch in 2024

Retrieved on: 
Tuesday, March 12, 2024
Partnership, Becker's, Oscar Health, Patient, Endoscopy, GI, Physician, Health, Gastroenterology, Nursing

ATLANTA, March 12, 2024 /PRNewswire/ -- United Digestive, a leading physician practice management organization serving GI physicians and gastroenterology practices nationwide, has been named by Becker's GI & Endoscopy as one of the top six gastroenterology companies to watch in 2024. The recognition underscores United Digestive's commitment to excellence in patient care and its innovative approach to gastroenterology.

Key Points: 
  • ATLANTA, March 12, 2024 /PRNewswire/ -- United Digestive, a leading physician practice management organization serving GI physicians and gastroenterology practices nationwide, has been named by Becker's GI & Endoscopy as one of the top six gastroenterology companies to watch in 2024.
  • The recognition underscores United Digestive's commitment to excellence in patient care and its innovative approach to gastroenterology.
  • In its publication, Becker's highlighted United Digestive's extensive network, which comprises more than 81 locations and 129 physicians.
  • "Being named one of the top gastroenterology companies to watch in 2024 is a tremendous honor and a testament to the hard work and dedication of our team," said Dr. Neal C. Patel, president of United Digestive.

Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract

Retrieved on: 
Wednesday, February 21, 2024
Pressure, Suction, Patent, Hospital, GI, Ser, Patient, Endoscopy, Literature

This latest patent covers the automated management of pressure for irrigation and self-purging feature of the latest generation of the Pure-Vu system.

Key Points: 
  • This latest patent covers the automated management of pressure for irrigation and self-purging feature of the latest generation of the Pure-Vu system.
  • This capability is key to enhancing the physician’s experience using the Pure-Vu, by avoiding procedure delays due to clogs,” commented Mark Pomeranz, Chief Executive Officer.
  • This latest patent application is a continuation of U.S. patent applications Ser.
  • Inpatient endoscopy on patients admitted to the hospital can be a difficult endeavor to get a quality procedure in a timely manner due to debris in the GI tract.

Internet of Medical Things (IoMT) Market to reach over US$ 385.01 Bn by the year 2031 - Explained Details | Exclusive Study by InsightAce Analytic

Retrieved on: 
Wednesday, February 21, 2024
Cloud, Caregiver, Privacy, Artificial intelligence, IoMT, AI, SAP, Privacy by design, Medtronic, Risk, GI, GE HealthCare, Patient, Endoscopy, Siemens Healthineers, Internet, Partnership, Medical device

This strategic agreement strengthens Medtronic's leadership in AI-integrated healthcare products and marks a significant step in implementing AI into endoscopic treatment.

Key Points: 
  • This strategic agreement strengthens Medtronic's leadership in AI-integrated healthcare products and marks a significant step in implementing AI into endoscopic treatment.
  • In October 2023, SAP SE reported that Siemens Healthineers AG's digital transformation journey will be enabled by the RISE with SAP solution.
  • @ https://www.insightaceanalytic.com/enquiry-before-buying/1559
    Internet of Medical Things (IoMT) Market Dynamics:
    Despite the evident potential of the Internet of Medical Things (IoMT), the market faces significant restrictions primarily stemming from heightened Data Security and Privacy Concerns.
  • Despite the evident potential of the Internet of Medical Things (IoMT), the market faces significant restrictions primarily stemming from heightened Data Security and Privacy Concerns.

Internet of Medical Things (IoMT) Market to reach over US$ 385.01 Bn by the year 2031 - Explained Details | Exclusive Study by InsightAce Analytic

Retrieved on: 
Wednesday, February 21, 2024
Cloud, Caregiver, Privacy, Artificial intelligence, IoMT, AI, SAP, Privacy by design, Medtronic, Risk, GI, GE HealthCare, Patient, Endoscopy, Siemens Healthineers, Internet, Partnership, Medical device

This strategic agreement strengthens Medtronic's leadership in AI-integrated healthcare products and marks a significant step in implementing AI into endoscopic treatment.

Key Points: 
  • This strategic agreement strengthens Medtronic's leadership in AI-integrated healthcare products and marks a significant step in implementing AI into endoscopic treatment.
  • In October 2023, SAP SE reported that Siemens Healthineers AG's digital transformation journey will be enabled by the RISE with SAP solution.
  • @ https://www.insightaceanalytic.com/enquiry-before-buying/1559
    Internet of Medical Things (IoMT) Market Dynamics:
    Despite the evident potential of the Internet of Medical Things (IoMT), the market faces significant restrictions primarily stemming from heightened Data Security and Privacy Concerns.
  • Despite the evident potential of the Internet of Medical Things (IoMT), the market faces significant restrictions primarily stemming from heightened Data Security and Privacy Concerns.

Waycen and MegaMind Sign AI Endoscopy supply Agreement to Medical market in the Middle East

Retrieved on: 
Monday, February 19, 2024
Hospital, Ministry, AI, Intelligence, Cough, Government, Megamind, Pentax, Certification, Medtech, Endoscopy, Medical device

Through this agreement, Waycen will leverage MegaMind IT Solution's extensive network in the Middle East healthcare market to introduce its artificial intelligence gastrointestinal endoscopy software 'WAYMED Endo' and AI respiratory self-screening service 'WAYMED Cough.'

Key Points: 
  • Through this agreement, Waycen will leverage MegaMind IT Solution's extensive network in the Middle East healthcare market to introduce its artificial intelligence gastrointestinal endoscopy software 'WAYMED Endo' and AI respiratory self-screening service 'WAYMED Cough.'
  • This collaboration aims to solidify Waycen's presence in the Middle East medical market.
  • MegaMind, IT Solution a specialized company located in Saudi Arabia, owns 13 group hospitals within the Middle East region.
  • Hamza Batterjee, the CEO of MegaMind, expressed his confidence in the agreement, saying, " MegaMind has a mission and confidence to lead digital innovation in the Middle East healthcare market."

EnLiSense CCM Advances Validation of Real-Time IBD Inflammatory Biomarker Monitoring with Two Recent Peer-Reviewed Longitudinal Studies

Retrieved on: 
Thursday, February 15, 2024
Hardware, Health Technology, Data Management, Other Health, Technology, Professional Services, Biometrics, Medical Devices, Genetics, Artificial Intelligence, Wearables, Mobile Technology, Biotechnology, Science, Data Analytics, Research, Health, Biosensor, Digital health, Ulcerative colitis, Senior, Doctor of Philosophy, Translation, Hasso Plattner Institute, Moses Austin, MD, Professor, Inflammation, Blood, IL-6, Quality of life, Bioelectronics, Gastrointestinal tract, Trial of the century, Scientific Reports, Management, University, Perspiration, CRP, Clinical, Inflammatory bowel disease, Patient, Biological engineering, Optimism, IBD, Conditional sentence, TNF, Endoscopy, National Institutes of Health, Medical imaging

Our innovative IBD Aware device offers the first solution for continuous, non-invasive monitoring of IBD through the power of sweat-sensing technology.

Key Points: 
  • Our innovative IBD Aware device offers the first solution for continuous, non-invasive monitoring of IBD through the power of sweat-sensing technology.
  • EnLiSense's journey reaches a significant milestone with over half a million human biomarker readings, underscoring the extensive validation of our technology.
  • These readings provide crucial data points, enhancing the precision and trustworthiness of inflammatory biomarker monitoring.
  • The studies involved measuring inflammation markers CRP, TNF-α, and IL-6 in subjects' blood and sweat continuously in subjects with and without IBD.

Dr. Matthew Ryan Reaches Milestone 100+ TNEs with the EvoEndo® Endoscopy System

Retrieved on: 
Wednesday, February 14, 2024
Health, Medical Devices, Hospitals, Surgery, Practice Management, Other Health, Biotechnology, Peter Hancock (professor), Physician, TNE, Patient, Anesthesia, Endoscopy, MD, Medical device

Dr. Joel Friedlander, Chief Medical Officer and co-founder at EvoEndo, congratulated Dr. Ryan on this significant milestone: "Dr. Ryan recognized the importance of making sedation-free TNE an option for his community, patients, and families.

Key Points: 
  • Dr. Joel Friedlander, Chief Medical Officer and co-founder at EvoEndo, congratulated Dr. Ryan on this significant milestone: "Dr. Ryan recognized the importance of making sedation-free TNE an option for his community, patients, and families.
  • By doing this, he is helping transform pediatric healthcare so endoscopic evaluation can be more accessible, more convenient, and without the need for anesthesia."
  • EvoEndo's Endoscopy System has opened new possibilities for unsedated TNE.
  • “Dr.

Zappix Reports Significant No-Show Reductions for its Gastroenterology and Endoscopy Clients Using Zappix Digital Patient Engagement Solutions During 2023

Retrieved on: 
Wednesday, February 14, 2024
Gastroenterology, Workflow, Endoscopy, Safety, Health, Patient, Nursing

BURLINGTON, Mass., Feb. 14, 2024 /PRNewswire-PRWeb/ -- Zappix, a Digital Patient Engagement Solutions leader, reports significant reductions in no-shows and late cancellations for Gastroenterology and Endoscopy clients utilizing its platform throughout 2023. This resulted in a transformative experience for both healthcare providers and their patients through increased operational efficiency, improved patient access, and optimized engagement.

Key Points: 
  • Zappix, a Digital Patient Engagement Solutions leader, reports significant reductions in no-shows and late cancellations for Gastroenterology and Endoscopy clients utilizing its platform throughout 2023.
  • BURLINGTON, Mass., Feb. 14, 2024 /PRNewswire-PRWeb/ -- Zappix , a Digital Patient Engagement Solutions leader, reports significant reductions in no-shows and late cancellations for Gastroenterology and Endoscopy clients utilizing its platform throughout 2023.
  • "Our Digital Patient Engagement Solution is revolutionizing the way healthcare providers optimize patient engagement, reduce operational inefficiencies, and improve access."
  • "Our Digital Patient Engagement Solution is revolutionizing the way healthcare providers optimize patient engagement, reduce operational inefficiencies, and improve access," said Yossi Abraham, President & CEO at Zappix.

Rady Children's Appoints Tom K. Lin, MD, as Rady Children's Hospital Medical Director of Pediatric Interventional Endoscopy and Professor of Clinical Pediatrics at the University of California San Diego

Retrieved on: 
Wednesday, February 14, 2024
SAN, Division, MD, Medical director, Physician, Pain, Clinical Pediatrics, Hospital, Gastrointestinal tract, Endoscopy, University, Specialization, UC, Rady Children's Hospital, Infant, Patient, Duke University, ERCP, Neuroscience, Wright State University, Nursing

SAN DIEGO, Feb. 14, 2024 /PRNewswire/ -- Rady Children's Hospital-San Diego , one of the nation's top pediatric health care systems, and the University of California San Diego are pleased to announce that Tom K. Lin, MD, has been appointed as Medical Director of Pediatric Interventional Endoscopy at Rady Children's Hospital and Professor of Clinical Pediatrics at UC San Diego School of Medicine.

Key Points: 
  • SAN DIEGO, Feb. 14, 2024 /PRNewswire/ -- Rady Children's Hospital-San Diego , one of the nation's top pediatric health care systems, and the University of California San Diego are pleased to announce that Tom K. Lin, MD, has been appointed as Medical Director of Pediatric Interventional Endoscopy at Rady Children's Hospital and Professor of Clinical Pediatrics at UC San Diego School of Medicine.
  • With more than 21 years of medical expertise, Dr. Lin will lead Rady Children's and UC San Diego's efforts to improve care for pediatric patients with pancreaticobiliary disorders; establishing the first interventional endoscopy program at Rady Children's.
  • Prior to his appointment, Dr. Lin spent 11 years at Cincinnati Children's Hospital, where he was instrumental in building the interventional endoscopy program from the ground up.
  • For pediatric patients with pancreaticobiliary disorders, interventional endoscopy represents a significant milestone in the fight against these diseases.

Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients

Retrieved on: 
Tuesday, February 13, 2024
Urinary tract infection, Gastroesophageal reflux disease, Research, Heartburn, Toxicity, Magnesium, Polyp, Liver, CYP, CGA, Achlorhydria, Esophagitis, Patient, PBM, Vitamin B12, Vonoprazan, Kidney, Spine, Lactation, Absorption, Hypokalemia, SCAR, Calcium, Express Scripts, TIN, Endoscopy, Tablet, Express, Magnesium deficiency, Hypocalcemia, Diarrhea, Hypersensitivity, Physician, Gastritis, Malabsorption, GERD, PPI, Hypertension, SJS, Enzyme inhibitor, EGFR, Stevens–Johnson syndrome, Indigestion, Nelfinavir, Clostridioides, Abdominal pain, Hip, Pharmacy, Enzyme, Glomus tumor, FDA, CDAD, Atazanavir, Risk, BMJ Open, Wrist, Drug, Impairment, Pharmaceutical industry

Given that most Erosive GERD patients have already undergone treatment with a PPI, and many continue to express dissatisfaction with their current regimens, we are pleased with this outcome.

Key Points: 
  • Given that most Erosive GERD patients have already undergone treatment with a PPI, and many continue to express dissatisfaction with their current regimens, we are pleased with this outcome.
  • doi:10.1136/ bmjgast-2022-000941
    VOQUEZNA® (vonoprazan) is a potassium-competitive acid blocker (PCAB) indicated:
    for the healing of all grades of Erosive Esophagitis (Erosive Gastroesophageal Reflux Disease or Erosive GERD) and relief of heartburn associated with Erosive GERD in adults.
  • for the maintenance of healing of all grades of Erosive GERD and relief of heartburn associated with Erosive GERD in adults.
  • Renal Impairment: For the healing of Erosive GERD, dosage reduction is recommended in patients with severe renal impairment (eGFR